When Drug Reps Visit: Darshan Reacts

Darshan reacts to a fake interaction between a drug sales representative and a doctor. He shares insights on pharmaceutical marketing tactics, highlighting that while doctors often find sales reps personable, they may not trust them as much as medical science liaisons (MSLs) due to limitations on what reps can legally discuss about drugs. Darshan explains industry regulations, such as the Pharma Code and the Sunshine Act, which restrict certain gifts to avoid conflicts of interest. He also critiques exaggerated claims by reps, such as new drugs having unprecedented benefits without comparative studies, stressing that the FDA requires rigorous evidence.Support the show

There are no comments yet.

Please log in to write the first comment.